Deferasirox
Who holds supplier records for Deferasirox? 25 organisations hold a current record for Deferasirox: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (19), China (2) and Netherlands (1); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Deferasirox: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/deferasirox
Reading the evidence
- 25 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
19 of the 22 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 11 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Deferasirox expires 21 Nov 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (25)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Deferasirox. Country is the organisation's recorded country, not necessarily the manufacturing site.
- TAPI NL BVNetherlandsCEPActive DMF 29548, 27648 · latest filing Jul 2015
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 26833 · latest filing Feb 2013
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 24209 · latest filing Oct 2010
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 34191 · latest filing Sept 2019
- Biocon LimitedIndiaCEPActive DMF 28626 · latest filing Jan 2015
- Ctx LifesciencesIndiaCEPActive DMF 38963 · latest filing Oct 2023
- MEDILUX LABORATORIES PVT LTDIndiaCEP Company GMP cert on recordActive DMF 30695 · latest filing Jun 2016
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 25837 · latest filing Feb 2012
- Neuland Laboratories LimitedIndiaCEPActive DMF 25733 · latest filing Jan 2012
- Viyash Scientific LtdIndiaCEP Company GMP cert on recordActive DMF 31877 · latest filing Nov 2019
- Zhejiang Hengkang Pharmaceutical Co., Ltd.ChinaCEPActive DMF 41051 · latest filing Dec 2024
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 35651 · latest filing Mar 2021
- Cipla LimitedIndia Company GMP cert on recordActive DMF 30817 · latest filing Sept 2016
- GLOBELA INDUSTRIES PRIVATE LTDActive DMF 44735 · latest filing Sept 2026
- JUBILANT BIOSYS LTDIndiaActive DMF 25888 · latest filing Mar 2012
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 22369 · latest filing Dec 2008
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 31485 · latest filing Mar 2017
- PURE AND CURE HEALTHCARE PRIVATE LTDIndiaActive DMF 25964 · latest filing Mar 2012
- SMS Pharmaceuticals limitedIndia Company GMP cert on recordActive DMF 41917 · latest filing May 2025
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 29320 · latest filing Aug 2015
- WATERSTONE PHARMACEUTICALS (HUBEI) CO LTDChinaActive DMF 28805, 41202 · latest filing Apr 2025
- YUNG ZIP CHEMICAL IND CO LTDActive DMF 31599 · latest filing May 2017
- IndiaCEP
- IndiaCEP Company GMP cert on record
- ULKAR KIMYA SANAYII VE TICARET ASCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (14)
Certificates of Suitability on the EDQM register for Deferasirox, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2020-280 - Rev 03 Deferasirox | Jul 2026 | — |
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2021-038 - Rev 02 Deferasirox | Jul 2026 | — |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2021-148 - Rev 02 Deferasirox | May 2026 | — |
| BAL PHARMA LIMITED Bengaluru | IN | CEP 2024-364 - Rev 00 Deferasirox | Mar 2026 | — |
| MEDILUX LABORATORIES PRIVATE LIMITED Pithampur | IN | CEP 2025-040 - Rev 00 Deferasirox | Jan 2026 | Inspected Nov 2025 Germany |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | CEP 2021-176 - Rev 01 Deferasirox | Apr 2025 | — |
| Ulkar Kimya Sanayii Ve Ticaret Anonim Sirketi Istanbul | TR | CEP 2023-310 - Rev 00 Deferasirox | Mar 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2021-111 - Rev 01 Deferasirox | Jan 2025 | — |
| ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. Sanmen | CN | CEP 2024-292 - Rev 00 Deferasirox | Dec 2024 | — |
| BIOCON LIMITED Bengaluru | IN | CEP 2022-080 - Rev 01 Deferasirox | Sept 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2020-348 - Rev 02 Deferasirox | Aug 2024 | — |
| CTX LIFESCIENCES PVT. LIMITED Surat | IN | R0-CEP 2021-493 - Rev 00 Deferasirox | Jul 2023 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | R0-CEP 2021-170 - Rev 02 Deferasirox | Mar 2023 | — |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | R0-CEP 2021-037 - Rev 00 Deferasirox | Mar 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Deferasirox are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- India · Inactive DMF 30213 · filed Jan 2016
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 28379 · filed Jun 2014
- Italy · Inactive DMF 26468 · filed Sept 2012
- Bachem SA, Succursale de VionnazSwitzerland · Inactive DMF 26003 · filed Apr 2012
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (84 listed products contain Deferasirox). The latest listed patent expires 21 Nov 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Deferasirox is an iron chelator used to reduce chronic iron overload in patients who receive long-term blood transfusions. It binds to iron and allows its elimination from the body, thereby preventing damage to organs from excess iron deposition.
Chemical identity
- IUPAC name
- 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid
- Canonical SMILES
- C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O
- InChIKey
- BOFQWVMAQOTZIW-UHFFFAOYSA-N
- Synonyms
- Exjade API, exjade, icl-670, icl-670a, icl670, icl670a, jadenu, jadenu sprinkle, osveral
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Iron Chelator
- Mechanism of action
- Cytochrome P450 1A2 Inhibitors; Cytochrome P450 2C8 Inhibitors; Cytochrome P450 3A4 Inducers; Iron Chelating Activity
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Deferasirox?
25 organisations hold an active US FDA Type II Drug Master File or a CEP for Deferasirox: TAPI NL BV (Netherlands), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), Biocon Limited (India), Ctx Lifesciences (India), MEDILUX LABORATORIES PVT LTD (India) and MSN Laboratories Private Limited (India), and 17 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Deferasirox Drug Master Files are active?
TAPI NL BV (DMF 29548, 27648), Alembic Pharmaceuticals Limited (DMF 26833), ALIVUS LIFE SCIENCES LTD (DMF 24209), APITORIA PHARMA PRIVATE LTD (DMF 34191), Biocon Limited (DMF 28626), Ctx Lifesciences (DMF 38963), MEDILUX LABORATORIES PVT LTD (DMF 30695) and MSN Laboratories Private Limited (DMF 25837) and 14 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Deferasirox records mean?
4 organisations have only inactive Type II DMFs for Deferasirox. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Deferasirox have a European Certificate of Suitability?
Yes. 14 organisations hold a valid CEP for Deferasirox on the EDQM register, including NEULAND LABORATORIES LIMITED Hyderabad (IN), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), BAL PHARMA LIMITED Bengaluru (IN), MEDILUX LABORATORIES PRIVATE LIMITED Pithampur (IN) and AMOLI ORGANICS PRIVATE LIMITED Mumbai (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Deferasirox?
Yes. The latest patent listed for an approved US product containing Deferasirox expires 21 Nov 2034, across 84 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Deferasirox supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Deferasirox?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.